Skip to main content
      RT @Stiddyo: Several domains of disease in #PsA need to be considered. Composite scores have the benefit of providing a

      Paul Studenic Stiddyo

      4 years 5 months ago
      Several domains of disease in #PsA need to be considered. Composite scores have the benefit of providing a summary. What is your favourite composite score for PsA in your clinical practice? #EULAR2021 @RheumNow
      Blindness with Tocilizumab in GCA: Is it a Worry? Dr. David Liew ( @drdavidliew )
      #EULAR2021

      https://t.co/xokPqGMEyA ht

      Dr. John Cush RheumNow

      4 years 5 months ago
      Blindness with Tocilizumab in GCA: Is it a Worry? Dr. David Liew ( @drdavidliew ) #EULAR2021 https://t.co/xokPqGMEyA https://t.co/NJ3PrFR6nF
      Check out this compilation of our EULAR 2021 Day 2 broadcasts below. You can also follow the EULAR 2021 RheumNow podcasts on iTunes and Soundcloud.com Listen by Clicking below: 1. EULAR2021 - Day2a 2. EULAR2021 - Day2b
      RT @Janetbirdope: After 1st JAKi in RA would you use a 2nd #Jaki? @eular_org

      Janet Pope Janetbirdope

      4 years 5 months ago

      After 1st JAKi in RA would you use a 2nd #Jaki? @eular_org

      RT @RichardPAConway: Given the data on poorer pregnancy outcomes in higher disease activity in RA in Abstr#OP0210, shoul

      Richard Conway RichardPAConway

      4 years 5 months ago
      Given the data on poorer pregnancy outcomes in higher disease activity in RA in Abstr#OP0210, should we alter our current management approach? @RheumNow #EULAR2021
      RT @uptoTate: The COSMOS study results showed that GUS 100 mg Q8W showed ⬆️ ACR20 vs PBO at W24 in TNFi IR PsA pts w

      Dr. Rachel Tate uptoTate

      4 years 5 months ago

      The COSMOS study results showed that GUS 100 mg Q8W showed ⬆️ ACR20 vs PBO at W24 in TNFi IR PsA pts who had tried 1-2 prior TNFi. What MOA do you choose after 1st TNFi IR in your PsA pts? Abstract #OP0230 #EULAR2021 @RheumNow https://t.co/Jb7GqkHtYz

      RT @drdavidliew: "The concept of JAK selectivity is based on in vitro assays, with limited impact on cellular and clinic

      David Liew drdavidliew

      4 years 5 months ago
      "The concept of JAK selectivity is based on in vitro assays, with limited impact on cellular and clinical aspecrts of the use of JAK inhibitors" - Hendrik Schulze-Koops, @LMU_Muenchen #EULAR2021 @RheumNow
      RT @drdavidliew: So what does JAK selectivity actually mean?
      How selective is selective?

      Hendrik Schulze-Koops #EULAR20

      David Liew drdavidliew

      4 years 5 months ago
      So what does JAK selectivity actually mean? How selective is selective? Hendrik Schulze-Koops #EULAR2021 @RheumNow https://t.co/Oh8wZCKcSj
      RT @KDAO2011: A biosimilar to placebo!
      #POS0276 study eval krill oil for knee pain.
      452 participants randomized to kri

      k dao KDAO2011

      4 years 5 months ago
      A biosimilar to placebo! #POS0276 study eval krill oil for knee pain. 452 participants randomized to krill oil 2 g/d X 24 wks. no difference in knee pain function, lipids, inflammation, leg strength or adverse events #EULAR2021 @rheumnow https://t.co/cajz6sfhzn
      RT @KDAO2011: Exercise won't flare your disease #POS0404
      Study of DBA/1 RA prone mice compared: exercised vs. not
      mice

      k dao KDAO2011

      4 years 5 months ago
      Exercise won't flare your disease #POS0404 Study of DBA/1 RA prone mice compared: exercised vs. not mice that exercised: - did NOT have⬆️in IL6, TNFa, IL17A - had⬇️levels of sclerostin - did NOT get enthesial mineralizat'n #EULAR2021 @rheumnow https://t.co/REP2UKp7Ci
      RT @Janetbirdope: JAKi has better retention than a bDMARD in RA! Single site study of RA pts prescribed advanced therapy

      Janet Pope Janetbirdope

      4 years 5 months ago

      JAKi has better retention than a bDMARD in RA! Single site study of RA pts prescribed advanced therapy in 320 Rxs in 215 pts JAKi lasted longer adjusting for age, sex, RA duration & line of therpy & 1st line Rx POS0205 #EULAR2021 @RheumNow https://t.co/4m2RXBkTDr

      RT @RichardPAConway: Dr Mulhearn presents that excess GCA cases are associated with COVID-19 peaks. Annual incidence rat

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Mulhearn presents that excess GCA cases are associated with COVID-19 peaks. Annual incidence rate of 13.7/100,000 in 2019 and 29.8/100,000 in 2020. Interesting, needs replication! @RheumNow #EULAR2021 Abstr#OP0281 https://t.co/kDk7ARnxMn
      RT @MeralElRamahiMD: Enthesitis response to SEC over 24w in PsA pts from ULTIMATE?

      ➡️ULTIMATE: 52w DB, PIII RCT tha

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 5 months ago
      Enthesitis response to SEC over 24w in PsA pts from ULTIMATE? ➡️ULTIMATE: 52w DB, PIII RCT that showed sign impr of synovitis (PDUS-detected) w/ SEC vs PBO in pts w/ PsA ➡️OP0226: SEC improved enthesitis at wk 12 & 24 per SPARCC & Global OMERACT-US scores #EULAR2021 @RheumNow https://t.co/QiCo4CVHz3
      RT @Yuz6Yusof: Can we identify #SLE patients who cd benefit from earlier bDMARDs? Dr Hassan showed 105/209(50%) pts requ

      Md Yuzaiful Md Yusof Yuz6Yusof

      4 years 5 months ago
      Can we identify #SLE patients who cd benefit from earlier bDMARDs? Dr Hassan showed 105/209(50%) pts required bDMARDs/Cyclophosphamide. Time-to-therapy was associated with⬇️C3/C4 and⬆️cSLEDAI-2K. More works needed re: biomarkers & varied population #EULAR2021 #POS0175 @RheumNow https://t.co/gK7Ew3WJUj
      ×